Dennis L Spangler

Summary

Country: USA

Publications

  1. ncbi request reprint Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis
    Dennis L Spangler
    Atlanta Allergy and Asthma Clinic, 1965 N Park Place, N W, Atlanta, GA 30339, USA
    South Med J 99:593-9. 2006
  2. ncbi request reprint Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models
    Dennis L Spangler
    Atlanta Allergy and Asthma Clinic, Atlanta, Georgia 30339, USA
    Clin Ther 25:2245-67. 2003
  3. ncbi request reprint Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge
    Bob Q Lanier
    Fort Worth Allergy Asthma Association, Texas 76132, USA
    Clin Ther 24:1161-74. 2002
  4. ncbi request reprint Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challenge
    Mark B Abelson
    Harvard Medical School, Schepens Eye Research Institute, Department of Ophthalmology, Boston, Massachusetts, USA
    Curr Eye Res 32:1017-22. 2007

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis
    Dennis L Spangler
    Atlanta Allergy and Asthma Clinic, 1965 N Park Place, N W, Atlanta, GA 30339, USA
    South Med J 99:593-9. 2006
    ..It is essential that appropriate treatment relieves SAR symptoms with absent or minimal adverse events. This is particularly important for those patients involved in skilled and cognitive activities or safety-critical jobs...
  2. ncbi request reprint Randomized, double-masked comparison of olopatadine ophthalmic solution, mometasone furoate monohydrate nasal spray, and fexofenadine hydrochloride tablets using the conjunctival and nasal allergen challenge models
    Dennis L Spangler
    Atlanta Allergy and Asthma Clinic, Atlanta, Georgia 30339, USA
    Clin Ther 25:2245-67. 2003
    ..Allergic rhinoconjunctivitis is typically treated with a nasal spray or systemic antihistamine, neither of which may provide adequate relief of the ocular component of the disease...
  3. ncbi request reprint Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge
    Bob Q Lanier
    Fort Worth Allergy Asthma Association, Texas 76132, USA
    Clin Ther 24:1161-74. 2002
    ..It has not yet been determined whether a topical or systemic agent is more effective for the latter purpose...
  4. ncbi request reprint Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challenge
    Mark B Abelson
    Harvard Medical School, Schepens Eye Research Institute, Department of Ophthalmology, Boston, Massachusetts, USA
    Curr Eye Res 32:1017-22. 2007
    ..1% and one drop of olopatadine 0.2%. Both showed significant activity at the 24-hour time point and were statistically superior to placebo. No adverse events occurred while on drug therapy...